Jefferies Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Jefferies Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-22,100	Closed	-$779K	–	3655
2015 Q1	$779K	Sell	22,100 -50,000	-69%	-$1.69M	﹤0.01%	1172
2014 Q4	$2.32M	Hold	72,100	–	–	0.01%	665
2014 Q3	$2.02M	Buy	+72,100	New	+$2.2M	0.01%	723
2014 Q2	–	Sell	-95,000	Closed	-$2.63M	–	2601
2014 Q1	$2.63M	Buy	+95,000	New	+$2.49M	0.03%	519

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Jefferies Group's BRLI Position: Q3 2015 in Review

Jefferies Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 109,672 shares — an estimated $4.52M sold.

Jefferies Group first reported a position in BRLI in Q1 2014 and held it in 5 quarters. The position peaked at $4.52M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Jefferies Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Jefferies Group sold 109,672 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $4.52M.
Jefferies Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 5 quarters.
Jefferies Group's BIO-REFERENCE LABS INC-NEW- position peaked at $4.52M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Jefferies Group's 13F filing for Q3 2015, filed 13 Nov 2015.